Clinical Trial Update: Empagliflozin's Microcirculatory Effects in Cardiogenic Shock: an Ancillary Pilot Study of the EMPASHOCK Trial [NA]

View source ↗

Summary

An ancillary pilot study exploring empagliflozin's microcirculatory effects in cardiogenic shock as part of the EMPASHOCK trial; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Cardiogenic Shock | NA | Status: ACTIVE_NOT_RECRUITING